St George's, University of London - Nosing ahead

Researchers at St George's, University of London have been awarded £4.3 million by the Wellcome Trust for the development of a new class of drugs that aims to target the root cause, instead of the symptoms, of asthma and allergies. The research team, led by Clive Robinson, professor of respiratory cell science, has identified novel, drug-like chemical compounds that combat asthma and allergic diseases of the nose, eyes and skin. The St George's team will work with colleagues from the University of Manchester to develop a drug for clinical trials in the next few years.